Skip to main content

The Toronto Stock Exchange’s S&P/TSX rose 8.70 points, or 0.05 per cent, to 16,052.24.

The biggest contributor to the TSX gain was Royal Bank of Canada and financials were the top sector contributor.

Leading the index were NexGen Energy Ltd, up 9.1 per cent, Hudson’s Bay Co, up 7.2 per cent, and Ivanhoe Mines Ltd, higher by 5.1 per cent.

Lagging shares were Tahoe Resources Inc, down 7.1 per cent, Raging River Exploration Inc, down 5.9 per cent, and Cenovus Energy Inc, lower by 5.7 per cent.

On the TSX 130 issues advanced and 114 declined as a 1.1-to-1 ratio favored advancers. There were 12 new highs and 2 new lows, with total volume of 172.0 million shares.

The most heavily traded shares by volume were Cenovus Energy Inc, Baytex Energy Corp and Canopy Growth Corp .

The TSX’s energy group fell 4.54 points, or 2.25 per cent, while the financials sector climbed 0.88 points, or 0.3 per cent.

West Texas Intermediate crude futures fell 1.41 per cent, or $0.92, to $64.89 a barrel. Brent crude fell 1.86 per cent, or $1.43, to $75.36.

The TSX is off 1 per cent for the year.

Tech rally helps Wall Street push higher, Nasdaq has record close

Wall Street’s three major indexes rose on Monday, led by a rally in tech stocks, pushing the Nasdaq to a record closing high as investors bet on a continuation of strong economic growth, while falling oil prices weighed on the energy sector.

Apple shares rose to their highest ever due to investor bets on its annual developers conference and Microsoft impressed with an acquisition, pushing the S&P 500 technology index to a record high, while led consumer stocks higher.

Better-than-expected U.S. jobs data for May was still key to investor optimism as traders turned their focus away from recent trade war fears.

“There’s momentum from Friday’s job report that’s spilled into Monday’s trading and helped propel stocks higher,” said Kristina Hooper, chief global market strategist at Invesco in New York.

However, while impressed “to see a jobs report so strong late in an economic expansion,” Hooper worried about the U.S. government’s announcement last week of steel and aluminium tariffs for Europe, Canada and Mexico, which ended a two-month exemption.

“The jobs report is looking in the rear-view mirror while the protectionist actions last week will impact the future,” she said. “Investors may be caught off guard if there is a negative impact to economic growth this year from protectionism.”

The Dow Jones Industrial Average rose 178.48 points, or 0.72 per cent, to 24,813.69, the S&P 500 gained 12.25 points, or 0.45 per cent, to 2,746.87.

The Nasdaq Composite added 52.13 points, or 0.69 per cent, to reach 7,606.46, a record closing high.

The S&P 500’s technology sector was the benchmark index’s biggest boost with a 0.8 per cent gain.

Apple unveiled its latest operating system iOS 12 at the conference and after paring some gains in the afternoon, it closed up 0.8 per cent.

Along with the jobs report, Kim Forrest, senior portfolio manager at Fort Pitt Capital Group in Pittsburgh, also cited Apple’s developer conference and Microsoft’s $7.5-billion deal to buy privately held coding website GitHub Inc as key drivers on Monday.

The consumer discretionary index was the biggest percentage gainer of the S&P’s 11 sectors, with a 1.1 per cent rise, while the energy sector was its biggest loser with a 0.9 per cent drop as oil prices fell on worries about growing U.S. production.

As well as the jobs report, Invesco’s Hooper said falling oil prices were helping sentiment around the consumer sector.

The Nasdaq Biotechnology Index underperformed the broader market with a 0.7 per cent decline as shares of cancer-focused companies moved after presentations at the American Society of Clinical Oncology’s meeting.

Nektar Therapeutics tumbled 41.8 per cent and weighed on the index after mixed results from its experimental cancer drug with Bristol-Myers Squibb’s Opdivo disappointed investors.

Bristol-Myers Squibb ended 3.2 per cent lower.

Merck, however, gained about 2.4 per cent after latest data showed its cancer drug Keytruda improved survival as a stand-alone treatment for a type of lung cancer.

Boeing rose 1.1 per cent, the biggest boost to the Dow, after the planemaker said it would partner with French aerospace firm Safran SA to make and service aircraft parts.

Advancing issues outnumbered declining ones on the NYSE by a 1.83-to-1 ratio; on Nasdaq, a 1.35-to-1 ratio favoured advancers.

The S&P 500 posted 46 new 52-week highs and five new lows; the Nasdaq Composite recorded 228 new highs and 44 new lows.

Volume on U.S. exchanges was 6.5 billion shares, compared with the 6.6 billion average for the last 20 sessions.


Interact with The Globe